Bio Pharma Dive
DECEMBER 8, 2020
Two cell therapies might soon be approved for the blood cancer. But a growing group of antibody drugs, several of which were showcased at ASH, aren't far behind.
World of DTC Marketing
DECEMBER 8, 2020
SUMMARY: Pharma has been relying on digital agencies for too long but agencies can’t begin to understand your audience like brand team members. Having a brand digital marketer constantly communicating with digital agencies is a waste of time and money. Pharma brands have come to rely too heavily on digital marketing agencies for a range of services, from paid media to actual website development.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 8, 2020
Doctors on Tuesday got a more detailed idea of how the therapy works and who might be eligible to take it, as results from a late-stage trial were presented at ASH.
BioPharma Reporter
DECEMBER 8, 2020
The US Food and Drug Administration (FDA) said there are âno specific safety concerns that would preclude issuance of an EUAâ for the investigational COVID-19 vaccine (BNT162b2) from US pharma giant, Pfizer, and its German partner BioNTech.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
DECEMBER 8, 2020
Agency staff didn't raise any red flags in their review of the companies' study results, documents released ahead of a key advisory committee meeting Thursday show.
BioSpace
DECEMBER 8, 2020
The COVID-19 vaccine under development by China’s Sinopharm is showing efficacy of 86%, health authorities from the United Arab Emirates reported this morning.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 8, 2020
Novartis has signed a multi-year agreement with RetinAI Medical, which will see the companies work together to use artificial intelligence (AI) tools to support ophthalmology and digital health projects. Both companies have already worked on pilot projects in this area. The first project under a new master agreement will involve a multi-centre international clinical study involving patients with neovascular age-related macular degeneration (nAMD).
NY Times
DECEMBER 8, 2020
The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused it to fall behind in the U.S.
BioSpace
DECEMBER 8, 2020
AstraZeneca and the University of Oxford published an interim analysis of their four Phase III clinical trials of AZD1222, their COVID-19 vaccine.
Scienmag
DECEMBER 8, 2020
Dwarfism occurring in less than a hundred years Credit: James Baxter-Gilbert Researchers from the DSI/NRF Center for Invasion Biology at Stellenbosch University in South Africa have found that, scarcely a hundred years after Guttural Toads were introduced to the islands of Mauritius and Réunion, their overall body size has been reduced by up to a […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
DECEMBER 8, 2020
UK regulators stated today that they have received two reports of potential allergic reactions linked to the COVID-19 vaccine from Pfizer and BioNTech.
Outsourcing Pharma
DECEMBER 8, 2020
An expert from the clinical research technology specialist discusses how trial teams can use real-world evidence to improve study inclusivity.
BioSpace
DECEMBER 8, 2020
Topline results from the Phase III SURPASS-1 trial show that a 40-week treatment with Eli Lilly's tirzepatide led to significant reductions in A1c and body weight in adults with type 2 diabetes.
Pharma Times
DECEMBER 8, 2020
A 90 year-old woman in Coventry has become the first person in the UK to be given the vaccine
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
DECEMBER 8, 2020
Documents related to the COVID-19 vaccine developed by Pfizer and BioNTech that were in possession of the European Medicines Agency have been accessed by hackers.
Scienmag
DECEMBER 8, 2020
Jonathan Roberge, professor at the Institut national de la recherche scientifique (INRS), is part of an international research team awarded with a prestigious grant Credit: Phil Bernard Photographe Inc. Jonathan Roberge, professor at the Institut national de la recherche scientifique (INRS), is part of an international research team awarded with a prestigious grant as part […].
BioSpace
DECEMBER 8, 2020
Although vaccines will be available pending approval, there are questions as to how many people will quickly receive the vaccine and when more will be available.
Scienmag
DECEMBER 8, 2020
Rice lab discovers light-driven catalyst forms olefins for drug, agrochemical manufacturing Credit: Rice University HOUSTON – (Dec. 8, 2020) – Inspired by light-sensing bacteria that thrive near hot oceanic vents, synthetic chemists at Rice University have found a mild method to make valuable hydrocarbons known as olefins, or alkenes. Like the bacteria, the researchers use […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
DECEMBER 8, 2020
There is a lot of complexity within the process of preparing treatments, medication and therapies for patient use. However, if you like a challenge, a career in translational management might be for you!
pharmaphorum
DECEMBER 8, 2020
Amanda Barrell speaks to Alfred Samuels on his experience of prostate cancer and diversifying clinical trials to include the Black, Asian and minority ethnic (BAME) community. Alfred Samuels’ stage 4 metastatic prostate cancer brought his 30-year career, which had seen him travel the world with the likes of Beyoncé, Oasis, and Bob Dylan, to a shuddering halt.
BioSpace
DECEMBER 8, 2020
Vaccines are on the cusp of being authorized for use against COVID-19, but there is still a significant need for other therapeutics that will help patients who contract the virus fight off the devastating effects of the disease.
Scienmag
DECEMBER 8, 2020
UC Riverside-led team looks back to find life beyond Credit: NASA/JPL-Caltech UC Riverside is leading one of the NASA Astrobiology Program’s eight new research teams tackling questions about the evolution and origins of life on Earth and the possibility of life beyond our solar system. The teams comprise the inaugural class of NASA’s Interdisciplinary Consortia […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
NY Times
DECEMBER 8, 2020
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.
Scienmag
DECEMBER 8, 2020
Credit: Xinyi Xiao, Penn State Additive manufacturing (AM) machinery has advanced over time, however, the necessary software for new machines often lags behind. To help mitigate this issue, Penn State researchers designed an automated process planning software to save money, time and design resources. Newer, five-axis machines are designed to move linearly along an x, […].
NY Times
DECEMBER 8, 2020
Dr. Chris Hingston was one of the first health care workers in Britain to receive a vaccination. He hopes that widespread use of the shots means that “life will change back to some normality.”.
Scienmag
DECEMBER 8, 2020
Researchers develop algorithms to enable drones to quickly switch between hover and forward flight Credit: U.S. Army ABERDEEN PROVING GROUND, Md. — When an aircraft veers upwards too much, the decrease in lift and increase in drag may cause the vehicle to suddenly plummet. Known as a stall, this phenomenon has prompted many drone manufacturers […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Times
DECEMBER 8, 2020
The charity is slashing £45 million from its research budget
Scienmag
DECEMBER 8, 2020
Credit: Kim Ratliff, Production Coordinator, Augusta University A key way radiation therapy and chemotherapy work is by making highly lethal double-strand breaks in the DNA of cancer cells. A Georgia Cancer Center scientist wants to help those therapies work better by better understanding the complex DNA damage repair process, because sometimes these therapies can inadvertently […].
pharmaphorum
DECEMBER 8, 2020
A new Health Union survey reveals that people with chronic conditions feel that telehealth, despite its convenience and increased use throughout the COVID-19 pandemic, is generally less preferable than in-person visits, but can still serve as an occasionally suitable alternative. The survey is the fifth in Health Union’s ongoing COVID-19 Consumer Attitudes and Health Behaviors Survey series that captures “snapshots in time” that track the perspectives and health behaviors of people with chronic
NY Times
DECEMBER 8, 2020
Queasy Americans, fighting upset stomachs and worries about the pandemic, have stocked up on prescription and over-the-counter medications, making them scarce in some parts of the country.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
288 
Let's personalize your content